Publications

← Return to the complete list of publications

A phase I trial of ribavirin and low-dose cytarabine for the treatment of relapsed and refractory acute myeloid leukemia with elevated eIF4E.

Assouline S, Culjkovic-Kraljacic B, Bergeron J, Caplan S, Cocolakis E, Lambert C, Lau CJ, Zahreddine HA, Miller WH, Borden KL

Segal Cancer Centre, Lady Davis Institute, Jewish General Hospital, McGill University katherine.borden@umontreal.ca sarit.assouline@mcgill.ca.

Haematologica 2015;100(1):e7-9.

Pubmed ID: 25425688

Follow IRIC

Logo UdeM